Merck Press Release (01/19/12)
Merck has announced that it has entered into an agreement to resolve all claims related to Vioxx in Canada. The agreement was signed by Merck and plaintiffs' representatives and is pending approval by courts in Canada's provinces. "This agreement is structured to provide certainty and finality toward resolving Vioxx cases in Canada for a fixed amount," said Bruce N. Kuhlik, executive vice president and general counsel of Merck. "Under the agreement, there will be an orderly, documented and objective process to examine individual claims to determine qualification." Under the terms of the agreement, Merck will pay a total amount of at least C$21,806,250 but not more than C$36,881,250. This would resolve all Vioxx certified class actions, putative class actions, other litigation and claims related to Vioxx in Canada.

Read the complete article